Advertisement
Screener

EXOZYMES INC. (EXOZ) Graph

EXOZ Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2026-06-30: Research and development $1.44M; Income tax (m); Net income -$2.88M.
  • 2026-03-31: Research and development $1.12M; Income tax (m); Net income -$2.37M.
  • 2025-12-31: Research and development $1.11M*; Income tax (m); Net income -$2.66M*.
  • 2025-09-30: Research and development $1.22M; Income tax (m); Net income -$2.29M.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endResearch and developmentIncome taxNet income
2026-06-30$1.44M(m)-$2.88M
2026-03-31$1.12M(m)-$2.37M
2025-12-31$1.11M*(m)-$2.66M*
2025-09-30$1.22M(m)-$2.29M
2025-06-30$802.99K(m)-$2.36M
2025-03-31$575.02K(m)-$1.86M
2024-09-30$723.49K(m)-$1.66M
2024-06-30$237.40K$2.14K-$1.36M
2024-03-31$277.58K(m)-$1.01M
2023-09-30$27.94K(m)-$520.60K
2023-06-30(m)(m)-$178.08K
2023-03-31(m)(m)-$241.15K

Revenue and expense 6 month

Period endResearch and developmentIncome taxNet income
2026-06-30$2.56M(m)-$5.25M
2025-06-30$1.38M(m)-$4.22M
2024-06-30$514.98K$2.14K-$2.37M

Revenue and expense 9 month

Period endRevenueResearch and developmentIncome taxNet income
2025-09-30(m)$2.59M(m)-$6.50M
2024-09-30(m)$1.24M$2.14K-$4.03M
2023-09-30$70.77K$67.09K(m)-$939.83K

Revenue and expense 12 month

Period endRevenueResearch and developmentIncome taxNet income
2025-12-31(m)$3.71M-$105.20K-$9.16M
2024-12-31(m)$1.87M(m)-$5.86M
2023-12-31$70.07K$527.48K$42.27K-$2.04M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BioAtla, Inc. (BCAB)United States$0.058B-0.21
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Tevogen Inc. (TVGN)United States$0.049B
Instil Bio, Inc. (TIL)United States$0.048B-1.73
BioStem Technologies, Inc. (BSEM)United States$0.069B
LeonaBio, Inc. (LONA)United States$0.047B-0.61
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02